Skip to main content

Table 1 Clinical characteristics and prognosis of hematologic malignancies and non - hematologic malignancies

From: Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale

  Non- hematologic malignancies (n = 17) Hematologic malignancies (n = 14) p-value
sex (male/female) 8/9 8/6  
symptoms seizure 16 (94.1%) 13 (92.9%) 1.000
  headache 11 (64.7%) 8 (57.1%) 0.724
  visual impairments blurred vision 8 (47.1%) 7 (50%) 1.000
blind 2 (11.8%) 0 0.488
cortical blindness 1 (5.9%) 2 (14.3%) 0.576
confusion 9 (53.0%) 4 (28.6%) 0.275
High blood pressure 12 (70.6%) 7 (50%) 0.288
Abnormal brain imaging Occipital lobe 13 (76.5%) 11 (78.6%) 1.000
  Parietal lobe 13 (76.5%) 10 (71.4%) 1.000
Frontal lobe 7 (41.2%) 6 (42.9%) 1.000
prognosis Complete remission 16 (94.1%) 9 (64.3%) 0.101
  Partial remission 0 3 (21.4%)
death 1 (5.9%) 2 (14.3%)